maximum rate of the covalent inactivation is comparable to that of the most potent inhibitors reported for the viral proteases and covalentinhibitor drugs currently in clinical use. The covalent inhibition appears to be very specific for the viral proteases. The inhibitor has a potent antiviral activity against SARS-CoV-2 and is also well tolerated by mice and rats in toxicity studies. These results suggest
SARS-CoV-2 的两种蛋白酶 PL pro和 M pro对于病毒的复制至关重要。使用基于结构的共药效团筛选方法,我们开发了一种新型双靶向抑制剂,该抑制剂对抑制SARS-CoV-2 的PL pro和 M pro具有同等效力。该抑制剂含有一种新型弹头,可以与任一酶的催化半胱氨酸残基形成共价键。共价失活的最大速率与目前临床使用的病毒蛋白酶和共价抑制剂药物报道的最有效的抑制剂相当。共价抑制似乎对病毒蛋白酶非常具有特异性。该抑制剂对 SARS-CoV-2 具有有效的抗病毒活性,并且在毒性研究中也被小鼠和大鼠良好耐受。这些结果表明,该抑制剂是开发治疗 COVID-19 药物的有希望的先导药物。
Fluorescent 1,4-Naphthoquinones To Visualize Diffuse and Dense-Core Amyloid Plaques in APP/PS1 Transgenic Mouse Brains
作者:Naewoo Neo Shin、Hanna Jeon、Youngeun Jung、Seungyeop Baek、Sejin Lee、Hee Chan Yoo、Gi Hun Bae、Keunwan Park、Seung-Hoon Yang、Jung Min Han、Ikyon Kim、YoungSoo Kim
DOI:10.1021/acschemneuro.9b00093
日期:2019.6.19
Recent clinical approvals of brain imaging radiotracers targeting amyloid-beta provided clinicians the tools to detect and confirm Alzheimer's disease pathology without autopsy or biopsy. While current imaging agents are effective in postsymptomatic Alzheimer's patients, there is much room for improvement in earlier diagnosis, hence prompting a need for new and improved amyloid imaging agents. Here we synthesized 41 novel 1,4-naphthoquinone derivatives and initially discovered 14 antiamyloidogenic compounds via in vitro amyloid-beta aggregation assay; however, qualitative analyses of these compounds produced conflicting results and required further investigation. Follow-up docking and biophysical studies revealed that four of these compounds penetrate the blood-brain barrier, directly bind to amyloid-beta aggregates, and enhance fluorescence properties upon interaction. These compounds specifically stain both diffuse and dense-core amyloid-beta plaques in brain sections of APP/PS1 double transgenic Alzheimer's mouse models. Our findings suggest 1,4-naphthoquinones as a new scaffold for amyloid-beta imaging agents for early stage Alzheimer's.
THE CHLORINATION OF 1,5-DIHYDROXYNAPHTHALENE
作者:R. H. THOMSON
DOI:10.1021/jo01161a008
日期:1948.5
Mylius, Chemische Berichte, 1885, vol. 18, p. 469
作者:Mylius
DOI:——
日期:——
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones
作者:Deepak Bhasin、Somsundaram N. Chettiar、Jonathan P. Etter、May Mok、Pui-Kai Li
DOI:10.1016/j.bmc.2013.05.017
日期:2013.8
In this paper, we report the structure-activity relationship studies of substituted 1,4-naphthoquinones for its anticancer properties. 1,4-Naphthoquinone, Juglone, Menadione, Plumbagin and LLL12.1 were used as lead molecules to design PD compounds. Most of the PD compounds showed improved antiproliferative activity in comparison to the lead molecule in prostate (DU-145), breast (MDA-MB-231) and colon (HT-29) cancer cell lines. PD9, PD10, PD11, PD13, PD14 and PD15 were found to be the most potent compound with an IC50 value of 1-3 mu M in all cancer cell lines. Fluorescent polarization assay was employed to study the inhibition of STAT3 dimerization by PD compounds. PD9 and PD18 were found to be potent STAT3 dimerization inhibitors. (C) 2013 Published by Elsevier Ltd.